Global Coartem (Artemether & Lumefantrine) Market Growth 2024-2030

Global Coartem (Artemether & Lumefantrine) Market Growth 2024-2030

The global Coartem (Artemether & Lumefantrine) market size is projected to grow from US$ 40310 million in 2023 to US$ 53960 million in 2030; it is expected to grow at a CAGR of 4.3% from 2024 to 2030.

LP Information, Inc. (LPI) ' newest research report, the “Coartem (Artemether & Lumefantrine) Industry Forecast” looks at past sales and reviews total world Coartem (Artemether & Lumefantrine) sales in 2023, providing a comprehensive analysis by region and market sector of projected Coartem (Artemether & Lumefantrine) sales for 2024 through 2030. With Coartem (Artemether & Lumefantrine) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Coartem (Artemether & Lumefantrine) industry.

This Insight Report provides a comprehensive analysis of the global Coartem (Artemether & Lumefantrine) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Coartem (Artemether & Lumefantrine) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Coartem (Artemether & Lumefantrine) market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Coartem (Artemether & Lumefantrine) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Coartem (Artemether & Lumefantrine).

United States market for Coartem (Artemether & Lumefantrine) is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Coartem (Artemether & Lumefantrine) is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Coartem (Artemether & Lumefantrine) is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Coartem (Artemether & Lumefantrine) players cover Novartis, Sanofi-Aventis, KPC Pharmaceuticals, Inc, Guangxi Xiancaotang Pharmaceutical Co., LTD and Guilin Pharmaceutical Co., Ltd, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Coartem (Artemether & Lumefantrine) market by product type, application, key manufacturers and key regions and countries.

Segmentation by type
Artemether
Lumefantrine

Segmentation by application
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Novartis
Sanofi-Aventis
KPC Pharmaceuticals, Inc
Guangxi Xiancaotang Pharmaceutical Co., LTD
Guilin Pharmaceutical Co., Ltd
Kerui Nanhai Pharmaceutical
Kunming Pharmaceutical

Key Questions Addressed in this Report

What is the 10-year outlook for the global Coartem (Artemether & Lumefantrine) market?

What factors are driving Coartem (Artemether & Lumefantrine) market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Coartem (Artemether & Lumefantrine) market opportunities vary by end market size?

How does Coartem (Artemether & Lumefantrine) break out type, application?

Please note: The report will take approximately 2 business days to prepare and deliver.